<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pleural fluid characteristics of common conditions</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pleural fluid characteristics of common conditions</h1>
<div class="graphic"><div class="figure"><div class="ttl">Pleural fluid characteristics of common conditions</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Suspected condition</td> <td class="subtitle1_left">Pleural fluid analysis</td> <td class="subtitle1_left">Diagnostic or other features</td> </tr> <tr> <td>Uncomplicated parapneumonic effusion</td> <td> <ul> <li>Serosanguinous, nonpurulent exudate</li> <li>Glucose variable but usually &gt;60 mg/dL</li> <li>pH usually normal to low (7.2 to 7.4; very low pH is unusual but usually &gt;7.2)</li> <li>Elevated WBC (PMNs)</li> </ul> </td> <td>Fluid nonloculated on imaging studies.</td> </tr> <tr class="highlight_gray_text"> <td>Complicated parapneumonic effusion/empyema</td> <td> <ul> <li>Serosanguinous or purulent exudate</li> <li>Glucose often &lt;40 mg/L (2.2 mmol/L)</li> <li>LDH usually markedly elevated (sometimes &gt;1000 units/L)</li> <li>Normal to low pH (&lt;7.15 supports need for pleural fluid drainage, empyema often has pH &lt;7)</li> <li>Elevated WBCs (PMNs)</li> </ul> </td> <td>Identification of microorganism on pleural fluid staining or culture. Frank pus is diagnostic of an empyema. Fluid loculated on imaging studies.</td> </tr> <tr> <td>Malignancy</td> <td> <ul> <li>Serous, serosanguinous, or sanguinous exudate; 10% may be transudative by Light's criteria</li> <li>Low glucose (may be &lt;40 mg/L [2.2 mmol/L] in some cases)</li> <li>Low pH (&lt;7.4; may be &lt;7.2 in some cases)</li> <li>Elevated WBC (PMNs; lymphocytes [if longstanding])</li> <li>Basophils &gt;10% suggests leukemic involvement of the pleura</li> </ul> </td> <td> <p>Identification of malignant cells on cytology or cell block is diagnostic (may need repeat sampling).</p> <p>Other features, including elevated amylase and ADA, are nonspecific.</p> High clinical suspicion with negative initial cytology warrants repeat thoracentesis for cytology or rapid progression to pleural biopsy.</td> </tr> <tr class="highlight_gray_text"> <td>CHF</td> <td> <ul> <li>Serous or serosanguinous transudate</li> <li>Normal glucose</li> <li>pH 7.4 to 7.55</li> <li>May contain WBC and RBC if associated bleeding</li> <li>Elevated serum and pleural fluid NT-proBNP</li> </ul> </td> <td>Classic features of pulmonary edema on chest radiography. Serum NT-proBNP usually suffices to support diagnosis of CHF, obviating need for pleural fluid NT-proBNP.</td> </tr> <tr> <td>Tuberculosis</td> <td> <ul> <li>Serous or serosanguinous exudate</li> <li>Low glucose (60 to 100 mg/dL [3.3 to 5.6 mmol/L] in many; &lt;50 mg/dL [2.8 mmol/L] in 20%; &lt;30 mg/dL [1.7 mmol/L] in &lt;10%)</li> <li>Low pH (&lt;7.4; pH &lt;7.30 in approximately 20% of cases)</li> <li>Elevated WBC (lymphocytes; occasionally PMNs in early disease)</li> <li>ADA &gt;40 units/L</li> <li>Mesothelial cells &gt;10% (in rare cases)</li> </ul> </td> <td>Identification of microorganism on microbiologic stain or culture is diagnostic.</td> </tr> <tr class="highlight_gray_text"> <td>Pancreatitis</td> <td> <ul> <li>Serous or serosanguinous exudate</li> <li>Normal glucose</li> <li>pH 7.4 to 7.55</li> <li>Pancreatic amylase 1000 IU/L</li> <li>Pleural fluid-to-serum amylase ratio &gt;2</li> <li>Elevated WBC (PMNs) and RBC if associated bleeding</li> </ul> </td> <td>Imaging and biochemical findings support the diagnosis of pancreatitis.</td> </tr> <tr> <td>Ruptured esophagus</td> <td> <ul> <li>Serous or serosanguinous exudate</li> <li>Low glucose (often &lt;40 mg/L [2.2 mmol/L])</li> <li>Low pH (often &lt;7.2)</li> <li>Elevated salivary amylase</li> <li>Food particles in pleural fluid</li> <li>Elevated WBC (typically PMNs)</li> </ul> </td> <td>Contrast imaging is typically required to demonstrate the ruptured viscus.</td> </tr> <tr class="highlight_gray_text"> <td>Chylothorax</td> <td> <ul> <li>Milky fluid (especially after a high-fat diet but may be serous or sanguinous)</li> <li>Exudative but sometimes transudative</li> <li>Normal glucose</li> <li>Low LDH</li> <li>Normal pH but may be low in patients with malignant chylous effusions</li> <li>Triglyceride ≥110 mg/dL (≥1.24 mmol/L)</li> <li>Lymphocyte predominance (&gt;70%)</li> </ul> </td> <td>A combination of lymphocytic effusion with pleural fluid triglyceride ≥110 mg/dL (1.24 mmol/L) in a patient with a known risk factor (eg, mediastinal trauma) is considered diagnostic. Lipoprotein analysis for chylomicrons may be needed in cases of uncertainty.</td> </tr> <tr> <td>Cholesterol effusion*</td> <td> <ul> <li>Milky fluid or turbid/cloudy (may rarely be serous or serosanguinous)</li> <li>Exudate</li> <li>Normal glucose</li> <li>Low to normal pH</li> <li>Lymphocyte predominance</li> <li>Cholesterol level usually &gt;200 mg/dL (5.17 mmol/L)</li> <li>Cholesterol-to-triglyceride ratio &gt;1</li> </ul> </td> <td>A combination of cholesterol ≥200 mg/dL (≥5.18 mmol/L), triglyceride &lt;110 mg/dL (1.24 mmol/L), and a cholesterol-to-triglyceride ratio &gt;1 in a patient with a known risk factor is typically sufficient to make the diagnosis. Rarely, the demonstration of cholesterol crystals under polarized light may be needed and is definitively diagnostic (absent in 10%).</td> </tr> <tr class="highlight_gray_text"> <td>Rheumatoid pleurisy</td> <td> <ul> <li>Local immunologic serositis: serous exudate</li> <li>Glucose may be &lt;50 mg/dL</li> <li>Elevated LDH</li> <li>pH may be &lt;7.2</li> <li>WBC elevated (PMNs if acute, mononuclear if chronic)</li> <li>RF elevated</li> <li>Complement decreased</li> <li>Rupture of necrotic subpleural rheumatoid nodules into pleural space: sterile empyema with yellow-green exudate, low pH, low glucose, elevated LDH</li> <li>Rheumatoid vasculitis of pleura: bloody effusion</li> <li>Chylothorax and cholesterol effusions may occur in RA</li> </ul> </td> <td>In pleural effusion due to serositis, cytology may show multinucleated giant cells (tadpole cells).</td> </tr> <tr> <td>SLE pleuritis</td> <td> <ul> <li>Usually small, bilateral serous or serosanguinous exudates</li> <li>Low glucose and pH in 20%</li> <li>Elevated WBC (PMNs; lymphocytes [if longstanding])</li> <li>Decreased complement</li> <li>ANA titer ≥1:160</li> </ul> </td> <td>ANA titer ≥1:160 is a sensitive tool for distinguishing lupus pleuritis from other effusions in patients with SLE. LE cell preparation and a pleural fluid-to-serum ANA ratio ≥1 are nonspecific.</td> </tr> <tr class="highlight_gray_text"> <td>Hemothorax</td> <td> <ul> <li>Bloody</li> <li>Exudative</li> <li>Normal glucose (similar to that of serum concentration)</li> <li>Normal to slightly low pH</li> <li>Elevated RBC, pleural fluid-to-blood hematocrit ratio &gt;0.5</li> </ul> </td> <td>A pleural fluid-to-blood hematocrit ratio &gt;0.5 is considered diagnostic of hemothorax.</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>WBC: white blood cells; PMNs: polymorphonuclear neutrophils; LDH: lactate dehydrogenase; ADA: adenosine deaminase; CHF: congestive heart failure; RBC: red blood cells; NT-proBNP: N-terminal pro-brain natriuretic peptide; IU: international units; RF: rheumatoid factor; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus; ANA: antinuclear antibody; LE: lupus erythematosus.</p>
* Features typical of rheumatoid or tuberculous pleurisy or of parasitic infection may complicate the picture.</div><div id="graphicVersion">Graphic 139766 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
